Nathalie Dubois Stringfellow Sangamo Therapeutics, Inc (SGMO) insider trading activity

Nathalie Dubois Stringfellow is SVP-CHIEF DEVELOPMENT OFFICER of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 844,598 shares of SGMO, which is worth approximately $1.44 Million. The most recent transaction as insider was on Aug 25, 2024, when has been sold 1,508 shares (Common Stock) at a price of $0.86 per share, resulting in proceeds of $1,296. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 845K

0.2% 3M change

500.56% 12M change

Total Value Held $1.44 Million

Nathalie Dubois-Stringfellow Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 25 2024	SELL Payment of exercise price or tax liability	$1,296 $0.86 p/Share	1,508 Reduced 0.18%	844,598 Common Stock
Aug 24 2024	SELL Payment of exercise price or tax liability	$1,536 $0.86 p/Share	1,787 Reduced 0.21%	846,106 Common Stock
May 25 2024	SELL Payment of exercise price or tax liability	$904 $0.6 p/Share	1,508 Reduced 0.18%	842,893 Common Stock
May 24 2024	SELL Payment of exercise price or tax liability	$1,072 $0.6 p/Share	1,787 Reduced 0.21%	844,401 Common Stock
Feb 25 2024	SELL Payment of exercise price or tax liability	$5,661 $1.13 p/Share	5,010 Reduced 0.59%	846,188 Common Stock
Feb 24 2024	SELL Payment of exercise price or tax liability	$6,185 $1.13 p/Share	5,474 Reduced 0.64%	851,198 Common Stock
Jan 22 2024	BUY Grant, award, or other acquisition	-	712,500 Added 45.41%	856,672 Common Stock
Nov 25 2023	SELL Payment of exercise price or tax liability	$555 $0.38 p/Share	1,462 Reduced 1.04%	139,172 Common Stock
Aug 25 2023	SELL Payment of exercise price or tax liability	$1,125 $0.77 p/Share	1,462 Reduced 1.03%	140,634 Common Stock
May 25 2023	SELL Payment of exercise price or tax liability	$1,944 $1.33 p/Share	1,462 Reduced 1.06%	137,096 Common Stock
Feb 25 2023	SELL Payment of exercise price or tax liability	$26,158 $2.66 p/Share	9,834 Reduced 6.63%	138,558 Common Stock
Feb 24 2023	BUY Grant, award, or other acquisition	-	53,438 Added 26.48%	148,392 Common Stock

Nathalie Dubois Stringfellow

SVP-CHIEF DEVELOPMENT OFFICER

Brisbane, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Value

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

Operation

Value

Type

News

Receive news related to SANGAMO THERAPEUTICS, INC

Track Activities on SGMO

Account